Eventide Asset Management, LLC Shockwave Medical, Inc. Transaction History

Eventide Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$191.17 - $325.63 $229,021 - $390,104	1,198 Added 0.24%	507,418 $165 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $24.2 Million - $32.5 Million	150,503 Added 42.31%	506,220 $96.5 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $22 Million - $32.2 Million	113,260 Added 46.71%	355,717 $70.8 Million
Q2 2023 Aug 15, 2023	BUY	$223.05 - $302.68 $129,815 - $176,159	582 Added 0.24%	242,457 $69.2 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $35.5 Million - $44.1 Million	202,175 Added 509.26%	241,875 $52.4 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $3.14 Million - $5 Million	16,100 Added 68.22%	39,700 $11 Million
Q2 2022 Aug 15, 2022	BUY	$115.91 - $214.48 $2.74 Million - $5.06 Million	23,600 New	23,600 $4.51 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.